Selected publications
-
A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032).
Annals of Thoracic Surgery.
2016
Academic Article
GET IT
Times cited: 21 -
Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance).
Annals of Thoracic Surgery.
2016
Academic Article
GET IT
Times cited: 7 -
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: Results from the ACOSOG Z4032 (Alliance) multicenter randomized trial.
Journal of Thoracic and Cardiovascular Surgery.
2015
Academic Article
GET IT
Times cited: 29 -
Impact of brachytherapy on local recurrence rates after sublobar resection: Results from ACOSOG Z4032 (alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.
Journal of Clinical Oncology.
2014
Academic Article
GET IT
Times cited: 54 -
Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: Results from a multicenter phase III study.
Journal of Thoracic and Cardiovascular Surgery.
2011
Academic Article
GET IT
Times cited: 42 -
The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: Preliminary results from the American College of Surgeons Oncology Group Z4032 Trial.
Journal of Thoracic and Cardiovascular Surgery.
2011
Academic Article
GET IT
Times cited: 20